Вступление

Вступление

^{‹‹1››.} Berzlanovich AM, Keil W, Waldhoer T, Sim E, Fasching P, Fazeny-Dorner B. Do centenarians die healthy? An autopsy study. J Gerontol A Biol Sci Med Sci. 2005;60(7):862–5.

^{‹‹2››.} Kohn RR. Cause of death in very old people. JAMA. 1982;247(20):2793–7.

^{‹‹3››.} Berzlanovich AM, Keil W, Waldhoer T, Sim E, Fasching P, Fazeny-Dorner B. Do centenarians die healthy? An autopsy study. J Gerontol A Biol Sci Med Sci. 2005;60(7):862–5.

^{‹‹4››.} Lenders C, Gorman K, Milch H, et al. A novel nutrition medicine education model: the Boston University experience. Adv Nutr. 2013;4(1):1–7.

^{‹‹5››.} Murray CJ, Atkinson C, Bhalla K, et al. The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310(6):591–608.

^{‹‹6››.} Kris-Etherton PM, Akabas SR, Bales CW, et al. The need to advance nutrition education in thetraining of health care professionals and recommended research to evaluate implementation and effectiveness. Am J Clin Nutr. 2014;99(5 Suppl):1153S–66S.

^{‹‹7››.} Swift CS. Nutrition trends: implications for diabetes health care professionals. Diabetes Spectr. 2009;29(1):23–5.

^{‹‹8››.} Vetter ML, Herring SJ, Sood M, Shah NR, Kalet AL. What do resident physicians know about nutrition? An evaluation of attitudes, self-perceived profi ciency and knowledge. J Am Coll Nutr. 2008;27(2):287–98.

^{‹‹9››.} Lazarus K, Weinsier RL, Boker JR. Nutrition knowledge and practices of physicians in a family-practice residency program: the effect of an education program provided by a physician nutrition specialist. Am J Clin Nutr. 1993;58(3):319–25.

^{‹‹10››.} Senate Committee on Business, Professions and Economic Development. Bill Analysis on SB 380. http://www.leginfo.ca.gov/pub/11-12/bill/sen/sb0351–0400/sb380cfa20110421_125358_sen_comm.html. Hearing held April 25, 2011. Accessed March 31, 2015.

^{‹‹11››.} The Medical Board of California. Continuing Medical Education. http://www.mbc.ca.gov/Licensees/Continuing_Education/. Nd. Accessed March 31, 2015.

^{‹‹12››.} Wizard Edison says doctors of future will give no medicine. Newark Advocate. January 2, 1903.

^{‹‹13››.} Stange KC, Zyzanski SJ, Jaen CR, et al. Illuminating the «black box.» A description of 4454 patient visits to 138 family physicians. J Fam Pract. 1998;46(5):377–89.

^{‹‹14››.} Aitken M, Johns Hopkins Bloomberg School of Public Health. The trillion dollar market for medicines: characteristics, dynamics and outlook. http://www.jhsph.edu/research/centers-and-institutes/center-for-drug-safety-and-effectiveness/academic-training/seminar-series/MUrray%20Aikten.pdf. February 24, 2014. Accessed March 29, 2015.

^{‹‹15››.} Willett WC. Balancing life-style and genomics research for disease prevention. Science. 2002;296(5568):695–8.

^{‹‹16››.} Willett WC. Balancing life-style and genomics research for disease prevention. Science. 2002;296(5568):695–8.

^{‹‹17››.} Robertson TL, Kato H, Rhoads GG, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Incidence of myocardial infarction and death from coronary heart disease. Am J Cardiol. 1977;39(2):239–43.

^{‹‹18››.} Mayo Clinic News Network. Nearly 7 in 10 Americans take prescription drugs, Mayo Clinic, Olmsted Medical Center Find. http://newsnetwork.mayoclinic.org/discussion/nearly-7-in-10-americans-take-prescription-drugs-mayo-clinic-olmsted-medical-center-find/. June 19, 2013. Accessed March 31, 2015.

^{‹‹19››.} Murray CJ, Atkinson C, Bhalla K, et al. The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310(6):591–608.

^{‹‹20››.} Crimmins EM, Beltran-Sanchez H. Mortality and morbidity trends: is there compression of morbidity? J Gerontol B Psychol Sci Soc Sci. 2011;66(1):75–86.

^{‹‹21››.} Crimmins EM, Beltr?n-S?nchez H. Mortality and morbidity trends: is there compression of morbidity? J Gerontol B Psychol Sci Soc Sci. 2011;66(1):75–86.

^{‹‹22››.} Olshansky SJ, Passaro DJ, Hershow RC, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005;352(11):1138–45.

^{‹‹23››.} Offord DR. Selection of levels of prevention. Addict Behav. 2000;25(6):833–42.

^{‹‹24››.} Gofrit ON, Shemer J, Leibovici D, Modan B, Shapira SC. Quaternary prevention: a new look at an old challenge. Isr Med Assoc J. 2000;2(7):498–500.

^{‹‹25››.} Strasser T. Reflections on cardiovascular diseases. Interdiscip Sci Rev. 1978;3(3):225–30.

^{‹‹26››.} Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121(4):586–613.

^{‹‹27››.} Yancy CW. Is ideal cardiovascular health attainable? Circulation. 2011;123(8):835–7.

^{‹‹28››.} Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121(4):586–613.

^{‹‹29››.} Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–52.

^{‹‹30››.} Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121(4):586–613.

^{‹‹31››.} Shay CM, Ning H, Allen NB, et al. Status of cardiovascular health in US adults: prevalence estimates from the National Health and Nutrition Examination Surveys (NHANES) 2003–2008. Circulation. 2012;125(1):45–56.

^{‹‹32››.} Shay CM, Ning H, Allen NB, et al. Status of cardiovascular health in US adults: prevalence estimates from the National Health and Nutrition Examination Surveys (NHANES) 2003–2008. Circulation. 2012;125(1):45–56.

^{‹‹33››.} Omran AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q. 1971;49(4):509–38.

^{‹‹34››.} US Centers for Disease Control and Prevention. Leading causes of death, 1900–1998. http://www.cdc. gov/nchs/data/dvs/lead1900_98.pdf. Accessed April 29, 2015.

^{‹‹35››.} Kochanek KD, Murphy SL, Xu J, Arias E. Mortality in the United States, 2013. NCHS Data Brief 2014;178.

^{‹‹36››.} Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859): 2224–60.

^{‹‹37››.} Popkin BM. Global nutrition dynamics: the world is shifting rapidly toward a diet linked with noncommunicable diseases. Am J Clin Nutr. 2006;84(2):289–98.

^{‹‹38››.} Zhai F, Wang H, Du S, et al. Prospective study on nutrition transition in China. Nutr Rev. 2009;67 Suppl 1:S56–61.

^{‹‹39››.} Singh PN, Arthur KN, Orlich MJ, et al. Global epidemiology of obesity, vegetarian dietary patterns, and noncommunicable disease in Asian Indians. Am J Clin Nutr. 2014;100 Suppl 1:359S–64S.

^{‹‹40››.} Singh PN, Arthur KN, Orlich MJ, et al. Global epidemiology of obesity, vegetarian dietary patterns, and noncommunicable disease in Asian Indians. Am J Clin Nutr. 2014;100 Suppl 1: 359S–64S.

^{‹‹41››.} McCarty MF. Proposal for a dietary «phytochemical index.» Med Hypotheses. 2004;63(5):813–7.

^{‹‹42››.} Mirmiran P, Bahadoran Z, Golzarand M, Shiva N, Azizi F. Association between dietary phytochemical index and 3-year changes in weight, waist circumference and body adiposity index in adults: Tehran Lipid and Glucose study. Nutr Metab (Lond). 2012;9(1):108.

^{‹‹43››.} Mirmiran P, Bahadoran Z, Golzarand M, Shiva N, Azizi F. Association between dietary phytochemical index and 3-year changes in weight, waist circumference and body adiposity index in adults: Tehran Lipid and Glucose study. Nutr Metab (Lond). 2012;9(1):108.

^{‹‹44››.} Golzarand M, Bahadoran Z, Mirmiran P, Sadeghian-Sharif S, Azizi F. Dietary phytochemical index is inversely associated with the occurrence of hypertension in adults: a 3-year follow-up (the Tehran Lipid and Glucose Study). Eur J Clin Nutr. 2015;69(3):392–8.

^{‹‹45››.} Golzarand M, Mirmiran P, Bahadoran Z, Alamdari S, Azizi F. Dietary phytochemical index and subsequent changes of lipid profile: a 3-year follow-up in Tehran Lipid and Glucose Study in Iran. ARYA Atheroscler. 2014;10(4):203–10.

^{‹‹46››.} Bahadoran Z, Karimi Z, Houshiar-Rad A, Mirzayi HR, Rashidkhani B. Dietary phytochemical index and the risk of breast cancer: a case control study in a population of Ira nian women. Asian Pac J Cancer Prev. 2013;14(5):2747–51.

^{‹‹47››.} U.S. Department of Agriculture Economic Research Ser vice. Loss-adjusted food availability. http://www.ers.usda.gov/datafiles/FoodAvailabily_Per_Capita_Data_System/LossAdjusted_FoodAvailability/calories.xls. September 30, 2014. Accessed April 29, 2015.

^{‹‹48››.} Wansink B, Kniffi n KM, Shimizu M. Death row nutrition. Curious conclusions of last meals. Appetite. 2012;59(3):837–43.

^{‹‹49››.} Bambs C, Kip KE, Dinga A, Mulukutla SR, Aiyer AN, Reis SE. Low prevalence of «ideal cardiovascular health» in a community-based population: the heart strategies concentrating on risk evaluation (Heart SCORE) study. Circulation. 2011;123(8):850–7.

^{‹‹50››.} Yancy CW. Is ideal cardiovascular health attainable? Circulation. 2011;123(8):835–7.

^{‹‹51››.} Ford ES, Bergmann MM, Krord J, Schienkiewitz A, Weikert C, Boeing H. Healthy living is the best revenge: findings from the European Prospective Investigation Into Cancer and Nutrition — Potsdam study. Arch Intern Med. 2009;169(15):1355–62.

^{‹‹52››.} Platz EA, Willett WC, Colditz GA, Rimm EB, Spiegelman D, Giovannucci E. Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men. Cancer Causes Control. 2000;11(7):579–88.

^{‹‹53››.} Wahls TL. The seventy percent solution. J Gen Intern Med. 2011;26(10):1215–6.

^{‹‹54››.} Ford ES, Bergmann MM, Boeing H, Li C, Capewell S. Healthy lifestyle behaviors and all-cause mortality among adults in the United States. Prev Med. 2012;55(1):23–7.

^{‹‹55››.} Khaw KT, Wareham N, Bingham S, Welch A, Luben R, Day N. Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study. PLoS Med. 2008;5(1):e12.

^{‹‹56››.} Jiang H, Ju Z, Rudolph KL. Telomere shortening and ageing. Z Gerontol Geriatr. 2007;40(5): 314–24.

^{‹‹57››.} Mather KA, Jorm AF, Parslow RA, Christensen H. Is telomere length a biomarker of aging? A review. J Gerontol A Biol Sci Med Sci. 2011;66(2):202–13.

^{‹‹58››.} Tsuji A, Ishiko A, Takasaki T, Ikeda N. Estimating age of humans based on telomere shortening. Forensic Sci Int. 2002;126(3):197–9.

^{‹‹59››.} Shammas MA. Telomeres, lifestyle, cancer, and aging. Curr Opin Clin Nutr Metab Care. 2011; 14(1):28–34.

^{‹‹60››.} Huzen J, Wong LS, van Veldhuisen DJ, et al. Telomere length loss due to smoking and metabolic traits. J Intern Med. 2014;275(2):155–63.

^{‹‹61››.} Hou L, Savage SA, Blaser MJ, et al. Telomere length in peripheral leukocyte DNA and gastric cancer risk. Cancer Epidemiol Biomarkers Prev. 2009;18(11):3103–9.

^{‹‹62››.} Gu Y, Honig LS, Schupf N, et al. Mediterranean diet and leukocyte telomere length in a multiethnic elderly population. Age (Dordr). 2015;37(2):9758.

^{‹‹63››.} Garc?a-Calz?n S, Moleres A, Mart?nez-Gonz?lez MA, et al. Dietary total antioxidant capacity is associated with leukocyte telomere length in a children and adolescent population. Clin Nutr. 2014;S0261–5614(14):00191–5.

^{‹‹64››.} Garc?a-Calz?n S, Moleres A, Mart?nez-Gonz?lez MA, et al. Dietary total antioxidant capacity is associated with leukocyte telomere length in a children and adolescent population. Clin Nutr. 2014;S0261–5614(14):00191–5.

^{‹‹65››.} Leung CW, Laraia BA, Needham BL, et al. Soda and cell aging: associations between sugarsweetened beverage consumption and leukocyte telomere length in healthy adults from the National Health and Nutrition Examination Surveys. Am J Public Health. 2014;104(12):2425–31.

^{‹‹66››.} Nettleton JA, Diez-Roux A, Jenny NS, Fitzpatrick AL, Jacobs DR. Dietary patterns, food groups, and telomere length in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr. 2008;88(5):1405–12.

^{‹‹67››.} Gu Y, Honig LS, Schupf N, et al. Mediterranean diet and leukocyte telomere length in a multiethnic elderly population. Age (Dordr). 2015;37(2):9758.

^{‹‹68››.} Flanary BE, Kletetschka G. Analysis of telomere length and telomerase activity in tree species of various life-spans, and with age in the bristlecone pine Pinus longaeva. Biogerontology. 2005; 6(2):101–11.

^{‹‹69››.} Ornish D, Lin J, Daubenmier J, et al. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol. 2008;9(11):1048–57.

^{‹‹70››.} Skordalakes E. Telomerase and the benefits of healthy living. Lancet Oncol. 2008;9(11):1023–4.

^{‹‹71››.} Ornish D, Lin J, Chan JM, et al. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol. 2013;14(11):1112–20.

^{‹‹72››.} Mason C, Risques RA, Xiao L, et al. Independent and combined effects of dietary weight loss and exercise on leukocyte telomere length in postmenopausal women. Obesity (Silver Spring). 2013;21(12):E549–54.

^{‹‹73››.} Ornish D, Lin J, Daubenmier J, et al. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol. 2008;9(11):1048–57.

^{‹‹74››.} Ornish D, Lin J, Chan JM, et al. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol. 2013;14(11):1112–20.

^{‹‹75››.} Artandi SE, Depinho RA. Telomeres and telomerase in cancer. Carcinogenesis. 2010;31(1): 9–18.

^{‹‹76››.} Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–322.

^{‹‹77››.} American Cancer Society. Cancer Facts & Figures 2015. Atlanta: American Cancer Society; 2015.

^{‹‹78››.} NHLBI Fact Book, Fiscal Year 2012. National Heart, Lung, and Blood Institute, NIH. http://www.nhlbi.nih.gov/files/docs/factbook/FactBook2012.pdf. February 2013. Accessed March 31, 2015.

^{‹‹79››.} Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–322.

^{‹‹80››.} Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).

^{‹‹81››.} American Cancer Society. Cancer Facts & Figures 2015. Atlanta: American Cancer Society; 2015.

^{‹‹82››.} Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).

^{‹‹83››.} Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).

^{‹‹84››.} Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–322.

^{‹‹85››.} Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).

^{‹‹86››.} American Cancer Society. Cancer Facts & Figures 2015. Atlanta: American Cancer Society; 2015.

^{‹‹87››.} Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).

^{‹‹88››.} Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).

^{‹‹89››.} Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).

^{‹‹90››.} Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).

^{‹‹91››.} Centers for Disease Control and Prevention. Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes. National Vital Statistics Report 2016;64(2).

^{‹‹92››.} Tuso PJ, Ismail MH, Ha BP, Bartolotto C. Nutritional update for physicians: plant-based diets. Perm J. 2013;17(2):61–6.

^{‹‹93››.} Egger GJ, Binns AF, Rossner SR. The emergence of «lifestyle medicine» as a structured approach for management of chronic disease. Med J Aust. 2009;190(3):143–5.

^{‹‹94››.} Hyman MA, Ornish D, Roizen M. Lifestyle medicine: treating the causes of disease. Altern Ther Health Med. 2009;15(6):12–4.

^{‹‹95››.} Willett WC. Balancing life-style and genomics research for disease prevention. Science. 2002;296(5568):695–8.

^{‹‹96››.} Hyman MA, Ornish D, Roizen M. Lifestyle medicine: treating the causes of disease. Altern Ther Health Med. 2009;15(6):12–4.

^{‹‹97››.} Allen J, Anderson DR, Baun B, et al. Reflections on developments in health promotion in the past quarter century from founding members of the American Journal of Health Promotion Editorial Board. Am J Health Promot. 2011;25(4):ei— eviii.

^{‹‹98››.} Tuso PJ, Ismail MH, Ha BP, Bartolotto C. Nutritional update for physicians: plant-based diets. Perm J. 2013;17(2):61–6.

^{‹‹99››.} Tuso PJ, Ismail MH, Ha BP, Bartolotto C. Nutritional update for physicians: plant-based diets. Perm J. 2013;17(2):61–6.

^{‹‹100››.} Tuso PJ, Ismail MH, Ha BP, Bartolotto C. Nutritional update for physicians: plant-based diets. Perm J. 2013;17(2):61–6.

^{‹‹101››.} Kono S. Secular trend of colon cancer incidence and mortality in relation to fat and meat intake in Japan. Eur J Cancer Prev. 2004;13(2):127–32.

^{‹‹102››.} Willett WC. Balancing life-style and genomics research for disease prevention. Science. 2002;296(5568):695–8.

^{‹‹103››.} Kono S. Secular trend of colon cancer incidence and mortality in relation to fat and meat intake in Japan. Eur J Cancer Prev. 2004;13(2):127–32.

^{‹‹104››.} Kulshreshtha A, Goyal A, Veledar E, et al. Association between ideal cardiovascular health and carotid intima-media thickness: a twin study. J Am Heart Assoc. 2014;3(1):e000282.

^{‹‹105››.} Corona M, Velarde RA, Remolina S, et al. Vitellogenin, juvenile hormone, insulin signaling, and queen honey bee longevity. Proc Natl Acad Sci USA. 2007;104(17):7128–33.

^{‹‹106››.} Kucharski R, Maleszka J, Foret S, Maleszka R. Nutritional control of reproductive status in honeybees via DNA methylation. Science. 2008;319(5871):1827–30.

^{‹‹107››.} Gnyszka A, Jastrzebski Z, Flis S. DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer. Anticancer Res. 2013;33(8):2989–96.

^{‹‹108››.} Joven J, Micol V, Segura-Carretero A, Alonso-Villaverde C, Menendez JA. Polyphenols and the modulation of gene expression pathways: can we eat our way out of the danger of chronic disease? Crit Rev Food Sci Nutr. 2014;54(8):985–1001.

^{‹‹109››.} Fang MZ, Wang Y, Ai N, et al. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 2003;63(22):7563–70.

^{‹‹110››.} Myzak MC, Tong P, Dashwood WM, Dashwood RH, Ho E. Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med (Maywood). 2007;232(2):227–34.

^{‹‹111››.} Dashwood RH, Ho E. Dietary histone deacetylase inhibitors: from cells to mice to man. Semin Cancer Biol. 2007;17(5):363–9.

^{‹‹112››.} Gryder BE, Sodji QH, Oyelere AK. Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed. Future Med Chem. 2012;4(4):505–24.

^{‹‹113››.} Ornish D, Magbanua MJ, Weidner G, et al. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci USA. 2008; 105(24): 8369–74.